IQV - IQVIA Holdings Inc.
NYSE
->
Healthcare
->
Diagnostics & Research
Durham,
United States
Type: Equity
IQV price evolution
IQV
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1376 | $1224 | $1382 | $1494 |
| Short term investments | $120 | $108 | $110 | $104 |
| Net receivables | $3381 | $3227 | $3139 | $3063 |
| Inventory | ||||
| Total current assets | $5596 | $5208 | $5329 | $5328 |
| Long term investments | $239 | $214 | $208 | $201 |
| Property, plant & equipment | $819 | $790 | $829 | $845 |
| Goodwill & intangible assets | $19406 | $19195 | $19120 | $18772 |
| Total noncurrent assets | $21085 | $20769 | $20707 | $20411 |
| Total investments | $359 | $322 | $318 | $305 |
| Total assets | $26681 | $25977 | $26036 | $25739 |
| Current liabilities | ||||
| Accounts payable | $3564 | $3133 | $3007 | $3143 |
| Deferred revenue | $1799 | $1838 | $1844 | $1827 |
| Short long term debt | $718 | $1309 | $1344 | $1343 |
| Total current liabilities | $6491 | $6589 | $6543 | $6657 |
| Long term debt | $13178 | $12539 | $12675 | $12088 |
| Total noncurrent liabilities | $14078 | $13583 | $13745 | $13150 |
| Total debt | $13896 | $13848 | $14019 | $13431 |
| Total liabilities | $20569 | $20172 | $20288 | $19807 |
| Shareholders' equity | ||||
| Retained earnings | $4692 | $4223 | $3920 | $3623 |
| Other shareholder equity | -$867 | -$903 | -$760 | -$731 |
| Total shareholder equity | $6112 | $5805 | $5748 | $5932 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1376 | $1216 | $1366 | $1814 |
| Short term investments | $120 | $93 | $111 | $88 |
| Net receivables | $3381 | $2960 | $2551 | $2410 |
| Inventory | ||||
| Total current assets | $5596 | $4981 | $4763 | $5090 |
| Long term investments | $239 | $162 | $164 | $162 |
| Property, plant & equipment | $819 | $863 | $903 | $953 |
| Goodwill & intangible assets | $19406 | $18741 | $18244 | $17859 |
| Total noncurrent assets | $21085 | $20356 | $19926 | $19474 |
| Total investments | $359 | $255 | $275 | $250 |
| Total assets | $26681 | $25337 | $24689 | $24564 |
| Current liabilities | ||||
| Accounts payable | $3564 | $645 | $2981 | $2813 |
| Deferred revenue | $1799 | $1797 | $1825 | $1252 |
| Short long term debt | $718 | $152 | $91 | $149 |
| Total current liabilities | $6491 | $5578 | $5241 | $4558 |
| Long term debt | $13178 | $12819 | $12347 | $12755 |
| Total noncurrent liabilities | $14078 | $13994 | $13406 | $13726 |
| Total debt | $13896 | $13011 | $12438 | $12904 |
| Total liabilities | $20569 | $19572 | $18647 | $18284 |
| Shareholders' equity | ||||
| Retained earnings | $4692 | $3334 | $2243 | $1277 |
| Other shareholder equity | -$867 | -$727 | -$406 | -$205 |
| Total shareholder equity | $6112 | $5765 | $6042 | $6001 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3868 | $3736 | $3728 | $3652 |
| Cost of revenue | $2478 | $2426 | $2443 | $2398 |
| Gross Profit | $1390 | $1310 | $1285 | $1254 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $556 | $502 | $482 | $513 |
| Total operating expenses | $889 | $829 | $761 | $783 |
| Operating income | $501 | $481 | $524 | $471 |
| Income from continuing operations | ||||
| EBIT | $548 | $535 | $547 | $501 |
| Income tax expense | -$102 | $51 | $81 | $71 |
| Interest expense | $181 | $181 | $169 | $141 |
| Net income | ||||
| Net income | $469 | $303 | $297 | $289 |
| Income (for common shares) | $469 | $303 | $297 | $289 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14984 | $14410 | $13874 | $11359 |
| Cost of revenue | $9745 | $9382 | $9233 | $7500 |
| Gross Profit | $5239 | $5028 | $4641 | $3859 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2053 | $2071 | $1964 | $1789 |
| Total operating expenses | $3262 | $3229 | $3248 | $3128 |
| Operating income | $1977 | $1799 | $1393 | $731 |
| Income from continuing operations | ||||
| EBIT | $2131 | $1767 | $1504 | $767 |
| Income tax expense | $101 | $260 | $163 | $72 |
| Interest expense | $672 | $416 | $375 | $416 |
| Net income | ||||
| Net income | $1358 | $1091 | $966 | $279 |
| Income (for common shares) | $1358 | $1091 | $966 | $279 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $469 | $303 | $297 | $289 |
| Operating activities | ||||
| Depreciation | $316 | $297 | $259 | $253 |
| Business acquisitions & disposals | -$30 | -$428 | -$432 | -$25 |
| Stock-based compensation | $45 | $47 | $50 | $75 |
| Total cash flows from operations | $747 | $583 | $402 | $417 |
| Investing activities | ||||
| Capital expenditures | -$179 | -$146 | -$160 | -$164 |
| Investments | -$4 | -$40 | ||
| Total cash flows from investing | -$212 | -$573 | -$596 | -$222 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$232 | -$144 | -$490 | -$187 |
| Net borrowings | -$186 | $8 | $594 | $336 |
| Total cash flows from financing | -$420 | -$144 | $95 | $87 |
| Effect of exchange rate | $37 | -$24 | -$13 | -$4 |
| Change in cash and equivalents | $152 | -$158 | -$112 | $278 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1358 | $1091 | $966 | $279 |
| Operating activities | ||||
| Depreciation | $1125 | $1130 | $1264 | $1287 |
| Business acquisitions & disposals | -$915 | -$1335 | -$1463 | -$167 |
| Stock-based compensation | $217 | $194 | $170 | $95 |
| Total cash flows from operations | $2149 | $2260 | $2942 | $1959 |
| Investing activities | ||||
| Capital expenditures | -$649 | -$674 | -$640 | -$616 |
| Investments | -$44 | -$5 | -$5 | -$11 |
| Total cash flows from investing | -$1603 | -$2006 | -$2103 | -$796 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$1053 | -$1239 | -$465 | -$491 |
| Net borrowings | $752 | $936 | $30 | $309 |
| Total cash flows from financing | -$382 | -$329 | -$1235 | -$217 |
| Effect of exchange rate | -$4 | -$75 | -$52 | $31 |
| Change in cash and equivalents | $160 | -$150 | -$448 | $977 |
News
Fundamentals
| Market cap | $41.40B |
|---|---|
| Enterprise value | $53.92B |
| Shares outstanding | 181.50M |
| Revenue | $14.98B |
|---|---|
| EBITDA | $3.26B |
| EBIT | $2.13B |
| Net Income | $1.36B |
| Revenue Q/Q | 3.45% |
| Revenue Y/Y | 3.98% |
| P/E ratio | 30.48 |
|---|---|
| EV/Sales | 3.60 |
| EV/EBITDA | 16.56 |
| EV/EBIT | 25.30 |
| P/S ratio | 2.76 |
| P/B ratio | 5.93 |
| Book/Share | 38.45 |
| Cash/Share | 7.58 |
| EPS | $7.48 |
|---|---|
| ROA | 5.20% |
| ROE | 23.02% |
| Debt/Equity | 3.37 |
|---|---|
| Net debt/EBITDA | 5.89 |
| Current ratio | 0.86 |
| Quick ratio | 0.86 |